Transcatheter Tricuspid Valve Repair Shows Significant Clinical Benefit in Severe Tricuspid Regurgitation

New research presented at ESC Congress 2026 and simultaneously published in the New England Journal of Medicine indicates that transcatheter tricuspid valve repair significantly improved clinical outcomes in high-risk patients with severe tricuspid regurgitation. The study demonstrated reductions in all-cause mortality and heart failure hospitalizations, as well as improvements in quality of life, establishing the intervention as an effective disease-modifying therapy.